Parkinson's disease Nervous System Diseases Parkinson's disease
Conditions
Interventions
After randomisation, both groups continued to receive their routine pharmacological treatment. The pharmacological treatment for both groups were the same. The intervention group received physical the
Sponsors
Razi University (Iran)
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Confirmed diagnosis of Parkinson's disease 2. Aged equal to or less than 65 years (male only) 3. Stage 2 or 3 Hoehn and Yahr scale 4. No cardiovascular, orthopaedic or other neurological disease 5. No cognitive impairment
Exclusion criteria
Exclusion criteria: Does not comply with the above inclusion criteria
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Activity of Daily Living (ADL) measured using the ADL subscale of the Short Parkinson's Evaluation Scale/Scales for Outcomes in Parkinson's disease (SPES/SCOPA) at baseline (after randomisation) and follow-up (after physical therapy - 12 weeks after randomisation). | — |
Primary
| Measure | Time frame |
|---|---|
| Quality of life (QOL) measured using the Parkinson's Disease Quality of Life (PDQL) questionnaire at baseline (after randomisation) and follow-up (after physical therapy - 12 weeks after randomisation). | — |
Countries
Iran
Outcome results
None listed